دورية أكاديمية
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease
| العنوان: | The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease |
|---|---|
| المؤلفون: | Müller-Ladner, UlfAff1, IDs40259023006163_cor1, Dignass, Axel, Gaffney, Karl, Jadon, Deepak, Matucci-Cerinic, MarcoAff5, Aff6, Lobaton, TrianaAff7, Aff8, Carron, PhilippeAff9, Aff10, Aff11, Gisbert, Javier P., Pande, Ira, Utzinger, Maximilian, Addison, Janet |
| المصدر: | BioDrugs. 37(6):873-889 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 11738804 1179190X |
|---|---|
| DOI: | 10.1007/s40259-023-00616-3 |